Grufity logo
Grufity logo
NDRA

NDRA - ENDRA Life Sciences Inc Stock Price, Fair Value and News

$4.59-0.26 (-5.36%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

Price Targets

NDRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NDRA Price Action

Last 7 days

10.3%

Last 30 days

-6.7%

Last 90 days

41.9%

Trailing 12 Months

36.5%

NDRA RSI Chart

NDRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NDRA Valuation

Market Cap

6.0M

Price/Earnings (Trailing)

-0.82

Price/Sales (Trailing)

1.1K

EV/EBITDA

-0.79

Price/Free Cashflow

-1.2

NDRA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

NDRA Fundamentals

NDRA Revenue

Revenue (TTM)

6.2K

NDRA Earnings

Earnings (TTM)

-7.3M

Earnings Growth (Yr)

-26.55%

Earnings Growth (Qtr)

58.62%

NDRA Profitability

Operating Margin

100.00%

EBT Margin

-118278.47%

Return on Equity

-408.67%

Return on Assets

-212.39%

Free Cashflow Yield

-83.24%

NDRA Investor Care

Shares Dilution (1Y)

120.69%

Diluted EPS (TTM)

-8.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2018265.3K178.9K92.5K6.2K
2017-460.9K406.3K351.6K
2016---515.6K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About ENDRA Life Sciences Inc

NDRA
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
 CEO
 WEBSITEendrainc.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES21

ENDRA Life Sciences Inc Frequently Asked Questions

NDRA is the stock ticker symbol of ENDRA Life Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of ENDRA Life Sciences Inc is 6.02 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, NDRA's PE ratio (Price to Earnings) is -0.82 and Price to Sales (PS) ratio is 1.11 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NDRA PE ratio will change depending on the future growth rate expectations of investors.